ClinicalTrials.gov
public full text
Public Domain
Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
This study was being done to assess the stomach emptying effect of a maximum dose of 3 mg Liraglutide compared to placebo in subjects who are overweight or obese. Liraglutide is a medication approved by the Food and Drug Administration (FDA) for routine clinical use.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance#180246
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes#143819
- Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)#195525
- To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study#825325
- Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes#321617
Record · ID 1172187
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive